enGene Therapeutics Inc. (NASDAQ:ENGN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Since at least Dec 18, 2023 |
| Michael Heffernan Other companies: Avalo Therapeutics, Inc. (Chairman of the Board · Since at least Mar 25, 2025); Biohaven Ltd. (Director · Since at least Sep 28, 2022); Trevi Therapeutics, Inc. (Lead Independent Director · Since at least May 7, 2019); Synlogic Inc (Director · Dec 8, 2020 – Jun 22, 2023 · Past); Biohaven Pharmaceutical Holding Co Ltd (Director · Jan 31, 2020 – Oct 3, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 2, 2021 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 21, 2016 – Dec 12, 2018 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – Feb 10, 2025 · Past); Ocata Therapeutics Inc (Director · Apr 11, 2012 – Feb 10, 2016 · Past) | Director · Since at least Jul 8, 2025 |
| Paul Hastings Other companies: Nkarta, Inc. (CHIEF EXECUTIVE OFFICER · Since at least Jul 9, 2020); Protara Therapeutics, Inc. (Director · Oct 18, 2016 – Jun 8, 2018 · Past); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past); OncoMed Pharmaceuticals Inc (Chairman & CEO · Jul 17, 2013 – Oct 10, 2017 · Past); Pacira BioSciences, Inc. (Director · Jun 2, 2011 – Jun 12, 2024 · Past) | Director · Since at least May 15, 2024 |
| Ron Cooper Other companies: C4 Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Generation Bio Co (Director · Since at least Mar 1, 2021); Albireo Pharma Inc (President and CEO, Director · Nov 3, 2016 – Mar 2, 2023 · Past) | Chief Executive Officer · Since at least Jul 22, 2024 |
| William Grossman Other companies: Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); Arcus Biosciences, Inc. (Chief Medical Officer · Apr 29, 2019 – Jun 16, 2021 · Past); Bellicum Pharmaceuticals Inc (Sr. VP, Chief Medical Officer · Feb 5, 2018 – Feb 5, 2019 · Past) | Director · Since at least Jul 8, 2025 |
| Constantine Chinoporos Other companies: Geron Corporation (Director · Since at least Mar 25, 2026); Applied Therapeutics Inc (See Remarks · Since at least Dec 28, 2023) | Interim Chief Business Officer · Since at least Jul 16, 2026 |
| Philip Astley-Sparke Other companies: Replimune Group, Inc. (Director · Since at least Jul 19, 2018); uniQure N.V. (Director · Jan 26, 2018 – Mar 2, 2021 · Past) | Director · Since at least Jul 8, 2025 |
| Richard Paul Bryce Other companies: Rain Oncology Inc (Chief Medical Officer · Apr 22, 2021 – Feb 15, 2023 · Past); Puma Biotechnology Inc (SEE REMARKS · Jun 20, 2012 – Apr 5, 2021 · Past) | Chief Medical Officer · Oct 31, 2023 – Nov 30, 2023 · Past |
| Wouter Joustra Other companies: Vor Biopharma Inc. (Director · Since at least Dec 18, 2025); NewAmsterdam Pharma Company N.V. (Director · Jul 16, 2024 – Jul 16, 2024 · Past) | Director · Since at least May 15, 2024 |
| Amy Pott Other companies: Wave Life Sciences Ltd. (Director · Sep 4, 2019 – Aug 18, 2020 · Past) | Chief Global Comm. Ofc. · Since at least May 27, 2025 |
| D Ryan Daws Other companies: Concert Pharmaceuticals Inc (Chief Financial Officer · Feb 12, 2014 – Jan 4, 2017 · Past) | Chief Financial Officer · Since at least Nov 27, 2023 |
| Gerald A Brunk Other companies: LAVA Medtech Acquisition Corp (President, Director · Oct 26, 2021 – Oct 26, 2021 · Past) | Director · Since at least Oct 31, 2023 |
| Jason David Hanson Other companies: BullFrog AI Holdings, Inc. (Director · Since at least Feb 13, 2023) | Chief Executive Officer, Director · Oct 31, 2023 – Oct 31, 2023 · Past |
| Jasper Bos Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026) | Director · Since at least Oct 31, 2023 |
| Jill Buck Other companies: Alaunos Therapeutics, Inc. (EVP, GM Gene Therapy · Jun 13, 2019 – Mar 4, 2021 · Past) | Chief Development Officer · Since at least Jul 8, 2025 |
| Lee Giguere Other companies: Chiasma Inc (General Counsel · Dec 5, 2019 – Aug 5, 2021 · Past) | Chief Legal Ofc. and Corp Secy · Since at least Jan 29, 2024 |
| Richard Glickman Other companies: ESSA Pharma Inc (Director · Since at least Oct 1, 2020) | Director · Since at least Oct 31, 2023 |
| Alexander Julian Nichols | Chief Strategy & Ops. Ofc · Since at least Oct 31, 2023 |
| Alexandre Jean-Rene Erwan Grassin | Int. Chief Financial Officer · Oct 31, 2023 – Oct 31, 2023 · Past |
| Anthony Tzeyew Cheung | Chief Scientific Officer · Since at least Oct 31, 2023 |
| Hussein Sweiti | Chief Medical Officer · Since at least Sep 29, 2025 |
| James Crowley Sullivan | Chief Scientific Officer · Oct 31, 2023 – Oct 31, 2023 · Past |
| Joan Connolly | Chief Technology Officer · Since at least Oct 21, 2024 |
| Kathleen P Richton | SVP, Finance and Treasurer · Since at least Jul 16, 2026 |
| Matthew Ross Boyd | Chief Regulatory Officer · Since at least Jul 8, 2025 |
| Raj Som Pruthi | Chief Medical Officer · Jul 22, 2024 – Jan 29, 2025 · Past |